Related Experiment Video

Updated: Feb 25, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

22.3K

End-Stage Renal Disease and Sudden Cardiac Death

Rahul Sakhuja1, Ashok J Shah2, Swapnil Hiremath3

  • 1Interventional Cardiology, Massachusetts General Hospital, 55 Fruit Street, GRB 800, Boston, MA 02114, USA.

Cardiac Electrophysiology Clinics
|August 4, 2017
PubMed

Insights

Patients with end-stage renal disease (ESRD) face a high risk of sudden cardiac death (SCD), often caused by ventricular arrhythmias. Current evidence for SCD assessment and management in ESRD patients remains limited.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Medicine

Background:

  • Patients with end-stage renal disease (ESRD) exhibit a significantly elevated risk for sudden cardiac death (SCD).
  • Ventricular arrhythmias are identified as the primary mechanism for SCD in this vulnerable population, mirroring trends in the general populace.
  • Metabolic disturbances unique to ESRD, coupled with prevalent traditional risk factors, contribute to the heightened SCD risk.

Purpose of the Study:

  • To review current data on risk factors for SCD in ESRD patients.
  • To evaluate the efficacy of medical and device-based therapies for SCD prevention and treatment in this cohort.
  • To assess the applicability of established risk stratification methods for SCD in ESRD.

Main Methods:

  • Literature review of existing studies on SCD in ESRD.
  • Analysis of data concerning risk factors, therapies, and risk stratification tools.
  • Synthesis of current evidence to inform clinical practice.

Main Results:

  • ESRD patients face a disproportionately high risk of SCD, primarily due to ventricular arrhythmias.
  • Metabolic derangements and traditional risk factors exacerbate SCD risk in ESRD.
  • Limited evidence exists for effective SCD assessment and management strategies in this population.

Conclusions:

  • Further research is crucial to develop targeted strategies for SCD prevention and management in ESRD.
  • Risk stratification tools need validation for their applicability in the ESRD population.
  • Addressing unique metabolic and traditional risk factors is key to reducing SCD in ESRD patients.

More Related Videos

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

3.1K
Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

853

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
892
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
474
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
834
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
433
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K